Provided by Tiger Fintech (Singapore) Pte. Ltd.

United Therapeutics

325.82
+6.111.91%
Post-market: 325.820.00000.00%18:31 EDT
Volume:317.05K
Turnover:103.04M
Market Cap:14.70B
PE:12.98
High:326.30
Open:322.99
Low:322.60
Close:319.71
Loading ...

United Therapeutics Corp : JP Morgan Cuts Target Price to $350 From $355

THOMSON REUTERS
·
01 May

Stock Track | United Therapeutics Soars 5.43% Pre-Market on Strong Q1 Earnings Beat and Robust Revenue Growth

Stock Track
·
30 Apr

Stock Track | United Therapeutics Soars 5.43% on Strong Q1 Results and Positive Outlook

Stock Track
·
30 Apr

United Therapeutics Corp reports results for the quarter ended March 31 - Earnings Summary

Reuters
·
30 Apr

United Therapeutics (UTHR) Reports Q1 Earnings: What Key Metrics Have to Say

Zacks
·
30 Apr

United Therapeutics (UTHR) Q1 Earnings and Revenues Top Estimates

Zacks
·
30 Apr

United Therapeutics Q1 Earnings, Revenue Rise

MT Newswires Live
·
30 Apr

United Therapeutics (NASDAQ:UTHR) Reports Bullish Q1

StockStory
·
30 Apr

United Therapeutics reports Q1 EPS $6.63, consensus $6.28

TIPRANKS
·
30 Apr

United Therapeutics: Q1 Earnings Snapshot

Associated Press Finance
·
30 Apr

United Therapeutics Q1 EPS $6.63 Beats $6.52 Estimate, Sales $794.40M Beat $729.83M Estimate

Benzinga
·
30 Apr

BRIEF-United Therapeutics Q1 Revenue USD 794.4 Million Vs. IBES Estimate USD 729.8 Million

Reuters
·
30 Apr

United Therapeutics Q1 2025: Revenue Up 17% to $794.4M, Net Income Rises 5%, EPS Increases 10%

Reuters
·
30 Apr

United Therapeutics Corp Q1 Shr View $6.53 -- Lseg Ibes Data

THOMSON REUTERS
·
30 Apr

United Therapeutics Corp: Qtrly EPS $6.63

THOMSON REUTERS
·
30 Apr

United Therapeutics Corporation Reports First Quarter 2025 Financial Results

Business Wire
·
30 Apr

United Therapeutics (UTHR) To Report Earnings Tomorrow: Here Is What To Expect

StockStory
·
29 Apr

Neurocrine Biosciences (NBIX) Q1 Earnings Preview: What's in the Cards?

Zacks
·
28 Apr

United Therapeutics Enters Credit Agreement With Wells Fargo - SEC Filing

Reuters
·
28 Apr

United Therapeutics (UTHR) Earnings Expected to Grow: Should You Buy?

Zacks
·
23 Apr